Author response for 'Changes in Plasma and Urine Metabolites Associated with Empagliflozin in Patients with Type 1 Diabetes'

Authors :: Jiwan Kim
Daniel Montemayor
Yuliya Lytvyn
Leif E. Lovblom
Daniel Scarr
Mir Tariq Ali
David Z.I. Cherney
Kumar Sharma
Vikas S. Sridhar
Patrick R. Lawler
Bruce A. Perkins
Hongping Ye
Hongyan Liu
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Type 1 diabetes
medicine.medical_specialty
business.industry
medicine
Empagliflozin
Urology
In patient
Urine
medicine.disease
business

Full Text Access

Tools